Growth Metrics

Merck (MRK) Net Income (2009 - 2026)

Merck (MRK) reported Net Income of -$4.2 billion for Q1 2026, down 182.77% year-over-year from $5.1 billion in Q1 2025, and down 242.1% on a QoQ basis from $3.0 billion in Q4 2025.

Merck (MRK) has 17 years of Net Income data on file, last reported at -$4.2 billion in Q1 2026.

  • Quarterly Net Income fell 182.77% year-over-year to -$4.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 billion (down 48.61% YoY) and the FY2025 annual result came in at $18.3 billion, up 6.6% from the prior year.
  • Net Income eased to -$4.2 billion in Q1 2026 per MRK's latest filing, from $3.0 billion in the prior quarter.
  • Across five years, Net Income topped out at $5.8 billion in Q3 2025 and bottomed at -$5.9 billion in Q2 2023.
  • The 4-year median for Net Income is $3.7 billion (2024), against an average of $2.4 billion.
  • The widest annual swing landed in 2024, when Net Income jumped 405.38%; it then plunged 182.77% in 2026.
  • Tracing MRK's Net Income over 4 years: stood at -$1.2 billion in 2023, then jumped by 405.38% to $3.7 billion in 2024, then fell by 20.89% to $3.0 billion in 2025, then slumped by 242.1% to -$4.2 billion in 2026.
  • Per Business Quant, the three latest MRK Net Income figures stand at -$4.2 billion (Q1 2026), $3.0 billion (Q4 2025), and $5.8 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 7.40 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 5.24 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 697.00 Mn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -4.21 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 2.02 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -13.00 Mn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 2.68 Bn
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.21 Bn
Dec 31, 2025 2.96 Bn
Sep 30, 2025 5.79 Bn
Jun 30, 2025 4.43 Bn
Mar 31, 2025 5.09 Bn
Dec 31, 2024 3.74 Bn
Sep 30, 2024 3.16 Bn
Jun 30, 2024 5.46 Bn
Mar 31, 2024 4.77 Bn
Dec 31, 2023 -1.23 Bn
Sep 30, 2023 4.75 Bn
Jun 30, 2023 -5.94 Bn
Mar 31, 2023 2.83 Bn
Dec 31, 2021 -62.00 Mn
Jun 30, 2021 332.00 Mn
Mar 31, 2021 437.00 Mn
Dec 31, 2020 523.00 Mn
Sep 30, 2020 617.00 Mn
Jun 30, 2020 661.00 Mn
Mar 31, 2020 3.22 Bn
Dec 31, 2019 -1.81 Bn
Sep 30, 2019 1.91 Bn
Jun 30, 2019 2.64 Bn
Mar 31, 2019 2.86 Bn
Dec 31, 2018 1.78 Bn
Sep 30, 2018 1.96 Bn
Jun 30, 2018 1.72 Bn
Mar 31, 2018 741.00 Mn
Dec 31, 2017 -1.04 Bn
Sep 30, 2017 -51.00 Mn
Jun 30, 2017 1.95 Bn
Mar 31, 2017 1.56 Bn
Dec 31, 2016 -587.00 Mn
Sep 30, 2016 2.19 Bn
Jun 30, 2016 1.21 Bn
Mar 31, 2016 1.13 Bn
Dec 31, 2015 982.00 Mn
Sep 30, 2015 1.83 Bn
Jun 30, 2015 688.00 Mn
Mar 31, 2015 958.00 Mn
Dec 31, 2014 7.33 Bn
Sep 30, 2014 842.00 Mn
Jun 30, 2014 2.03 Bn
Mar 31, 2014 1.73 Bn
Dec 31, 2013 815.00 Mn
Sep 30, 2013 1.15 Bn
Jun 30, 2013 935.00 Mn
Mar 31, 2013 1.62 Bn
Dec 31, 2012 949.00 Mn
Sep 30, 2012 1.76 Bn
Jun 30, 2012 1.82 Bn
Mar 31, 2012 1.77 Bn
Dec 31, 2011 1.54 Bn
Sep 30, 2011 1.72 Bn
Jun 30, 2011 2.05 Bn
Mar 31, 2011 1.07 Bn
Dec 31, 2010 -1.65 Bn
Sep 30, 2010 372.00 Mn
Jun 30, 2010 780.00 Mn
Mar 31, 2010 359.00 Mn
Dec 31, 2009 13.03 Bn
Sep 30, 2009 -1.01 Bn
Jun 30, 2009 394.00 Mn
Mar 31, 2009 802.80 Mn